Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,020.00
-105.00 (-4.94%)
Dec 19, 2024, 3:19 PM KST

Kangstem Biotech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Cash & Equivalents
1,3165,8564,6817,5429,9697,681
Upgrade
Short-Term Investments
24,50431,50431,00839,01824,8017,000
Upgrade
Trading Asset Securities
--988.8210,0263,16433,543
Upgrade
Cash & Short-Term Investments
25,82137,36036,67856,58537,93348,224
Upgrade
Cash Growth
31.09%1.86%-35.18%49.17%-21.34%28.00%
Upgrade
Accounts Receivable
596.36721.61,5671,225660.58332.51
Upgrade
Other Receivables
582.19411.99651.07326.35213.852.06
Upgrade
Receivables
1,9191,1342,2181,551874.38384.57
Upgrade
Inventory
785.37578.26467.15763.77354.86266.39
Upgrade
Prepaid Expenses
32330.83330.06326.9626.0938.16
Upgrade
Other Current Assets
7,3307,9636,2136,1285,5626,495
Upgrade
Total Current Assets
35,88647,36645,90765,35544,75155,408
Upgrade
Property, Plant & Equipment
18,94429,57231,26534,12634,79434,978
Upgrade
Long-Term Investments
7,5482,9501,8332,19867020,633
Upgrade
Other Intangible Assets
364.98440.121,041991.531,1211,789
Upgrade
Long-Term Accounts Receivable
--0-0-0-00
Upgrade
Other Long-Term Assets
1,384925.66546.68477.681,169835.79
Upgrade
Total Assets
64,12881,25380,592103,14882,505113,644
Upgrade
Accounts Payable
327.94324.27406.56850.37385.4616.81
Upgrade
Accrued Expenses
319.57483.99436.08421.19304.28284.76
Upgrade
Short-Term Debt
3,3302,6162,5662,2642,19812,345
Upgrade
Current Portion of Long-Term Debt
4005,5303,7003,500355.5683.33
Upgrade
Current Portion of Leases
575.44808.9752.43844.37829.4472.54
Upgrade
Current Unearned Revenue
330330334.05235.77300.01522.08
Upgrade
Other Current Liabilities
6,8068,5016,0729,0747,8336,274
Upgrade
Total Current Liabilities
12,08918,59414,26717,19112,20620,599
Upgrade
Long-Term Debt
3,1803,3805,2305,63012,42714,804
Upgrade
Long-Term Leases
124.211,2741,1201,8052,3483,228
Upgrade
Other Long-Term Liabilities
1,2766,3756,3016,3236,1445,579
Upgrade
Total Liabilities
16,66931,13027,89031,86233,86644,924
Upgrade
Common Stock
28,02727,96918,96918,96912,41810,425
Upgrade
Additional Paid-In Capital
174,869174,895163,374163,374131,311134,808
Upgrade
Retained Earnings
-162,508-159,354-137,201-117,054-95,670-77,232
Upgrade
Comprehensive Income & Other
7,0704,4694,1942,7513,2901,100
Upgrade
Total Common Equity
47,45947,97849,33668,03951,35069,101
Upgrade
Minority Interest
--3,494-2,110-2,070-2,981-2,001
Upgrade
Shareholders' Equity
47,45950,12352,70271,28648,63968,719
Upgrade
Total Liabilities & Equity
64,12881,25380,592103,14882,505113,644
Upgrade
Total Debt
7,61013,60913,36914,04418,15930,933
Upgrade
Net Cash (Debt)
18,21123,75123,30942,54219,77517,291
Upgrade
Net Cash Growth
164.19%1.90%-45.21%115.13%14.37%-14.67%
Upgrade
Net Cash Per Share
336.41584.98614.401527.64886.87829.71
Upgrade
Filing Date Shares Outstanding
56.0555.9437.9437.9424.8420.85
Upgrade
Total Common Shares Outstanding
56.0555.9437.9437.9424.8420.85
Upgrade
Working Capital
23,79728,77231,64048,16532,54434,809
Upgrade
Book Value Per Share
846.66857.701300.441793.432067.503314.26
Upgrade
Tangible Book Value
47,09447,53848,29567,04850,22967,311
Upgrade
Tangible Book Value Per Share
840.15849.831273.001767.302022.353228.44
Upgrade
Land
3,9278,2497,9847,9847,7981,243
Upgrade
Buildings
9,24110,92010,59610,59610,2112,762
Upgrade
Machinery
414.67595.05590.8533.4539.11522.21
Upgrade
Construction In Progress
548.74310.2223.5250.96-25,964
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.